Highlights Senseonics Holdings, Inc.

Equities

SENS

US81727U1051

Real-time Estimate Cboe BZX Other stock markets 10:19:15 2024-05-22 am EDT			5-day change	1st Jan Change
0.469 ^USD	-0.17%		-5.22%	-17.59%

May. 13	Transcript : Senseonics Holdings, Inc., Q1 2024 Earnings Call, May 13, 2024
May. 13	Earnings Flash (SENS) SENSEONICS HOLDINGS Posts Q1 Revenue $5.1M, vs. Street Est of $4.6M	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (SENS) SENSEONICS HOLDINGS Posts Q1 Revenue $5.1M, vs. Street Est of $4.6M	May. 13	MT
Senseonics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution	May. 09	CI
Senseonics Holdings, Inc. Announces Eversense CGM System Receives iCGM Designation by the U.S. Food and Drug Administration	Apr. 30	CI
Senseonics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Senseonics Holdings, Inc. Provides Revenue Guidance for the First Half of 2024	Feb. 29	CI
Earnings Flash (SENS) SENSEONICS HOLDINGS Posts Q4 Revenue $8M, vs. Street Est of $7.6M	Feb. 29	MT
Senseonics Q4 Revenue Guidance Tops Consensus	Jan. 02	MT
Earnings Flash (SENS) SENSEONICS HOLDINGS Reports Q3 Revenue $6.1M, vs. Street Est of $5.5M	Nov. 09	MT
Senseonics Holdings, Inc. Provides Earnings Guidance for the Year 2023	Nov. 09	CI
Senseonics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Senseonics Holdings, Inc. Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study	23-09-26	CI
Senseonics Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Senseonics Holdings, Inc. Reiterates Revenue Guidance for the Full Year 2023	23-08-10	CI
Earnings Flash (SENS) SENSEONICS HOLDINGS Reports Q2 Revenue $4.1M, vs. Street Est of $4.49M	23-08-10	MT
Sensonics Holdings, Inc. Announces New Clinical Data Demonstrating the Safety and Accuracy of Eversense Through 365 Days Presented at the American Diabetes Association 83rd Scientific Sessions	23-06-26	CI
Senseonics Says UnitedHealthcare to Cover Eversense E3 Continuous Glucose Monitoring System; Shares Rise	23-06-02	MT
Senseonics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Earnings Flash (SENS) SENSEONICS HOLDINGS Posts Q1 Revenue $4.1M	23-05-09	MT
Senseonics Holdings, Inc. Reiterates Revenue Guidance for the Full Year 2023	23-05-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Senseonics Holdings, Inc.

Equities

SENS

US81727U1051

Highlights

Filters